INTERNATIONAL PATENT: KINIKSA PHARMACEUTICALS, GMBH FILES APPLICATION FOR "FORMULATIONS OF ANTI-INTERLEUKIN 1 RECEPTOR 1 ANTIBODIES"

GENEVA, Jan. 5 -- KINIKSA PHARMACEUTICALS, GMBH (Grafenaustrasse 56300 Zug) filed a patent application (PCT/IB2025/056476) for "FORMULATIONS OF ANTI-INTERLEUKIN 1 RECEPTOR 1 ANTIBODIES" on Jun 25, 2025. With publication no. WO/2026/003765, the details related to the patent application was published on Jan 02, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): D'SOUZA, Ajit (c/o Kiniksa Pharmaceuticals Corp.100 Hayden AvenueLexington, Massachusetts 02421), XU, Jianwen (c/o Kiniksa Pharmaceuticals Corp.100 Hayden AvenueLexington, Massachusetts 02421)

Abstract: The present invention provides, amo...